VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL [ANCILLARY OF 700049031]
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 03 Feb 2017
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms VITAL-DEP
- 27 Jan 2017 Planned End Date changed from 1 Oct 2017 to 1 Dec 2017.
- 27 Jan 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Dec 2017.
- 08 Apr 2014 According to the ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.